ヘルスケアにおけるコールドプラズマ市場- 世界の産業規模、シェア、動向、機会、予測、用途別（創傷治癒、外科用途、その他の医療用途）、地域別、競合別、2020-2030年

世界のヘルスケアにおけるコールドプラズマ市場は2024年に21億4,000万米ドルと評価され、2030年には42億5,000万米ドルに達すると予測され、予測期間中のCAGRは12.11%で成長します。

非熱的、非侵襲的なイオン化ガス技術であるコールドプラズマは、創傷治癒、滅菌、がん治療、皮膚科治療など幅広い応用で現代のヘルスケアに変革をもたらしつつあります。健康な組織にダメージを与えることなく、病原体を破壊し、組織再生を促進し、血管新生を刺激するその能力は、貴重な医療ツールとなっています。

特に糖尿病やがんなど、高度で低侵襲な治療が必要な疾患において顕著です。冷血漿は、慢性創傷の管理や感染制御の支援において有望な結果を示しており、特にパンデミック後のヘルスケア戦略において極めて重要です。さらに、空気中のウイルスをほぼ瞬時に不活性化するコールドプラズマの可能性が学術的・臨床的に調査され、呼吸療法への応用に関心が高まっています。こうした開発は、多様な医療現場において、信頼性が高く革新的な治療・滅菌ソリューションとしてコールドプラズマ技術の採用が増加していることを裏付けています。

主な市場促進要因

慢性疾患の増加

主な市場課題

ヘルスケア・ワークフローへの統合

主な市場動向

データ主導型ヘルスケア

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のヘルスケアにおけるコールドプラズマ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別（創傷治癒、外科用途、その他の医療用途）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のヘルスケアにおけるコールドプラズマ市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のヘルスケアにおけるコールドプラズマ市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のヘルスケアにおけるコールドプラズマ市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のヘルスケアにおけるコールドプラズマ市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのヘルスケアにおけるコールドプラズマ市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収

第13章 世界のヘルスケアにおけるコールドプラズマ市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替治療法の脅威

第15章 競合情勢

• Neoplas med GmbH
• U.S. Medical Innovations
• Terumo Medical Corp
• Adtec Plasma Technology Co Ltd
• Apyx Medical Corp
• Nordson Corp
• Europlasma NV
• Terraplasma GmbH
• Henniker Plasma
• Smith & Nephew plc

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Cold Plasma in Healthcare Market was valued at USD 2.14 Billion in 2024 and is projected to reach USD 4.25 Billion by 2030, growing at a CAGR of 12.11% during the forecast period. Cold plasma, a non-thermal, non-invasive ionized gas technology, is transforming modern healthcare with its wide range of applications, including wound healing, sterilization, cancer therapy, and dermatological treatments. Its ability to destroy pathogens, promote tissue regeneration, and stimulate angiogenesis without damaging healthy tissue makes it a valuable medical tool.

The market is gaining momentum as chronic disease prevalence rises globally, particularly in conditions like diabetes and cancer that require advanced, minimally invasive treatments. Cold plasma is showing promising results in managing chronic wounds and aiding infection control-especially crucial in post-pandemic healthcare strategies. Additionally, with academic and clinical research highlighting cold plasma's potential to inactivate airborne viruses almost instantly, interest has surged for respiratory therapy applications. These developments underscore the increasing adoption of cold plasma technology as a reliable, innovative therapeutic and sterilization solution across diverse medical settings.

Key Market Drivers

Increasing Chronic Diseases

The growing burden of chronic diseases such as cancer, diabetes, and cardiovascular disorders is a major factor driving demand for cold plasma technologies in healthcare. According to the World Health Organization, noncommunicable diseases (NCDs) accounted for over 43 million deaths in 2021, with a disproportionate impact in low- and middle-income countries.

Cold plasma has emerged as a promising treatment modality for addressing the complications arising from these conditions. For instance, in diabetic patients, chronic ulcers present a persistent challenge; cold plasma accelerates healing by enhancing tissue oxygenation and reducing microbial load. Similarly, its application in oncology helps target cancer cells while sparing healthy tissue, offering an advanced alternative to traditional therapies. As healthcare systems globally aim to manage rising NCDs with precision and minimal side effects, the role of cold plasma technologies is becoming increasingly significant.

Key Market Challenges

Integration into Healthcare Workflows

One of the critical challenges in the cold plasma healthcare market is integrating these advanced technologies into established clinical workflows. Many healthcare facilities operate within strict procedural frameworks and require seamless compatibility with existing medical infrastructure.

Adopting cold plasma devices involves not only purchasing equipment but also modifying infrastructure, allocating physical space, and ensuring adequate training for clinical staff. These adjustments may be resource-intensive and time-consuming, particularly in smaller hospitals or facilities in developing regions. Without smooth integration, the potential clinical benefits of cold plasma may be underutilized or delayed, hampering market expansion despite the technology's efficacy.

Key Market Trends

Data-Driven Healthcare

The shift toward data-driven healthcare is reshaping how cold plasma devices are utilized. The integration of smart sensors and real-time monitoring capabilities allows healthcare providers to collect treatment data-such as gas flow, temperature, and dosage metrics-during procedures.

These insights enhance treatment precision and improve outcomes. For instance, in wound care, real-time feedback helps clinicians adjust parameters on-the-fly to accelerate healing. In oncology, data analytics can optimize dosage delivery to ensure cancer cells are effectively targeted. The ability to personalize treatment protocols based on real-time patient data marks a critical step in aligning cold plasma technology with the broader movement toward precision medicine and connected healthcare systems.

Key Market Players

• Neoplas med GmbH
• U.S. Medical Innovations
• Terumo Medical Corp
• Adtec Plasma Technology Co Ltd
• Apyx Medical Corp
• Nordson Corp
• Europlasma NV
• Terraplasma GmbH
• Henniker Plasma
• Smith & Nephew plc

Report Scope:

In this report, the Cold Plasma in Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cold Plasma in Healthcare Market, By Application:

• Wound Healing
• Surgical Application
• Other Medical Applications

Cold Plasma in Healthcare Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Cold Plasma in Healthcare Market.

Available Customizations:

Cold Plasma in Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cold Plasma in Healthcare Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Wound Healing, Surgical Application and Other Medical Applications)
  • 5.2.2. By Region
  • 5.2.3. By Company (2024)
• 5.3. Market Map

6. North America Cold Plasma in Healthcare Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cold Plasma in Healthcare Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
  • 6.3.2. Canada Cold Plasma in Healthcare Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
  • 6.3.3. Mexico Cold Plasma in Healthcare Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application

7. Europe Cold Plasma in Healthcare Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cold Plasma in Healthcare Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
  • 7.3.2. United Kingdom Cold Plasma in Healthcare Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
  • 7.3.3. Italy Cold Plasma in Healthcare Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Application
  • 7.3.4. France Cold Plasma in Healthcare Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
  • 7.3.5. Spain Cold Plasma in Healthcare Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application

8. Asia-Pacific Cold Plasma in Healthcare Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cold Plasma in Healthcare Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
  • 8.3.2. India Cold Plasma in Healthcare Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
  • 8.3.3. Japan Cold Plasma in Healthcare Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
  • 8.3.4. South Korea Cold Plasma in Healthcare Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
  • 8.3.5. Australia Cold Plasma in Healthcare Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application

9. South America Cold Plasma in Healthcare Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cold Plasma in Healthcare Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
  • 9.3.2. Argentina Cold Plasma in Healthcare Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
  • 9.3.3. Colombia Cold Plasma in Healthcare Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application

10. Middle East and Africa Cold Plasma in Healthcare Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cold Plasma in Healthcare Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
  • 10.3.2. Saudi Arabia Cold Plasma in Healthcare Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
  • 10.3.3. UAE Cold Plasma in Healthcare Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions

13. Global Cold Plasma in Healthcare Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Treatment Types

15. Competitive Landscape

• 15.1. Neoplas med GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Product & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. U.S. Medical Innovations
• 15.3. Terumo Medical Corp
• 15.4. Adtec Plasma Technology Co Ltd
• 15.5. Apyx Medical Corp
• 15.6. Nordson Corp
• 15.7. Europlasma NV
• 15.8. Terraplasma GmbH
• 15.9. Henniker Plasma
• 15.10. Smith & Nephew plc

16. Strategic Recommendations

17. About Us & Disclaimer